Search:   [Advanced]

Search Results

Search for "Gentamicin" returned 18 results

Showing 1-18 out of 18

DrugBank ID	Name	Formula	Weight
DB00798	Gentamicin	C21H43N5O7	477.5954
	... Sulfate + Sodium Chloride) Gentamicin Sulfate in Nacl 0.9% Inj (Gentamicin Sulfate + Sodium Chloride) Gentocin Durafilm (Betamethasone 21-Acetate + Gentamicin Sulfate) Gentocin Otic Solution ...
DB04729	GENTAMICIN C1A	C19H39N5O7	449.5423
	... 4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-methylaminooxane-3,5-diol GENTAMICIN C1A 72396 8142724 449.5423 449.
DB00955	Netilmicin	C21H41N5O7	475.5795
	... sisomycin, an aminoglycoside antibiotic with action similar to gentamicin, but less ear and kidney toxicity. [PubChem] Solution Intravenous 00503371 DB00955 2.5 hours CIDUJQMULVCIBT-IULVMANBBU ...
DB00438	Ceftazidime	C22H22N6O7S2	546.5760
	... to ceftazidime in vitro, including strains resistant to gentamicin and other aminoglycosides. In addition, ceftazidime has been shown to be active against gram-positive organisms. It is highly ...
DB04263	G418	C20H40N4O10	496.5524
	... is an aminoglycoside antibiotic similar in structure to gentamicin B1. It is produced by Micromonospora rhodorangea. G418 blocks polypeptide synthesis by inhibiting the elongation step in both ...
DB00043	Omalizumab	C6450H9916N1714O2023S38	145058.2000
	... culture in a nutrient medium containing the antibiotic gentamicin. Powder, for solution Subcutaneous 02260565 DB00043 J00228 26 days For treatment of asthma caused by allergies Humanized anti ...
DB00095	Efalizumab
	... system in a nutrient medium containing the antibiotic gentamicin. Powder, for solution Subcutaneous 02272504 DB00095 5 days For the treatment of adult patients with moderate to severe chronic ...
DB00112	Bevacizumab
	... system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons. Solution Intravenous 02270994 DB00112 For treatment of metastatic ...
DB01330	Cefotetan	C17H17N7O8S4	575.6190
	... Dicumarol The cephalosporin increases the anticoagulant effect Gentamicin Increased risk of nephrotoxicity Kanamycin Increased risk of nephrotoxicity Neomycin Increased risk of nephrotoxicity ...
DB01331	Cefoxitin	C16H17N3O7S2	427.4520
	... Dicumarol The cephalosporin increases the anticoagulant effect Gentamicin Increased risk of nephrotoxicity Kanamycin Increased risk of nephrotoxicity Neomycin Increased risk of nephrotoxicity ...
DB01607	Ticarcillin	C15H16N2O6S2	384.4270
	Ticarcillin may inactivate Gentamicin in vitro and the two agents should not be administered simultaneously through the same IV line. Kanamycin Ticarcillin may reduce the serum concentration of ...
DB00493	Cefotaxime	C16H17N5O7S2	455.4650
	Amikacin Increased risk of nephrotoxicity Gentamicin Increased risk of nephrotoxicity Kanamycin Increased risk of nephrotoxicity Neomycin Increased risk of nephrotoxicity Netilmicin Increased risk ...
DB00887	Bumetanide	C17H20N2O5S	364.4160
	... Digoxin Possible electrolyte variations and arrhythmias Gentamicin Increased ototoxicity Ginseng Ginseng decreases the therapeutic effect of diuretic Ibuprofen The NSAID decreases the diuretic ...
DB01212	Ceftriaxone	C18H18N8O7S3	554.5800
	... Dicumarol The cephalosporin increases the anticoagulant effect Gentamicin Increased risk of nephrotoxicity Kanamycin Increased risk of nephrotoxicity Neomycin Increased risk of nephrotoxicity ...
DB00695	Furosemide	C12H11ClN2O5S	330.7440
	... Fosphenytoin The hydantoin decreases the effect of furosemide Gentamicin Increased ototoxicity Ginseng Ginseng decreases the therapeutic effect Ibuprofen The NSAID decreases the diuretic and ...
DB00903	Ethacrynic acid	C13H12Cl2O4	303.1380
	... Digoxin Possible electrolyte variations and arrhythmias Gentamicin Increased ototoxicity Ginseng Ginseng decreases the therapeutic effect of diuretic Ibuprofen The NSAID decreases the diuretic ...
DB01041	Thalidomide	C13H10N2O4	258.2295
	Gentamicin Thalidomide increases the renal toxicity of the aminoglycoside Natalizumab Thalidomide may increase the adverse effects of Natalizumab. Concurrent administration should be avoided due ...
DB00864	Tacrolimus	C44H69NO12	804.0182
	... occur during concomitant therapy with aminoglycosides such as Gentamicin. Use caution during concomitant therapy. Halofantrine Additive QTc-prolongation may occur increasing the risk of ...

Showing 1-18 out of 18

This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.